Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-10-14, Stock:JNJ, The news for the past five days is as follows:
2021-10-07: NEWS1: Booster discussion 'a bit convoluted': Doctor.NEWS2: 'Administrative hurdles' could delay pediatric vaccine distribution: Doctor.NEWS3: 'Vaccine mandates are proving to work’: Doctor on Covid-19.NEWS4: 10 Dividend Stocks to Increase Your Monthly Income.NEWS5: What Do Mix-and-Match Doses Mean for Vaccine Stocks?.
2021-10-08: NEWS1: Studies claim Pfizer vaccine is less effective after a few months.NEWS2: Covid-19 Vaccine Boosters Are Outpacing First Doses. What Vaccine Stocks Are Doing..NEWS3: Covid-19 Vaccine Boosters Now Outpace First Doses, CDC Data Show.NEWS4: Johnson & Johson Asks FDA for Wider Use of Juvenile Arthritis Drug.NEWS5: 10 Boring Stocks That Make Money.NEWS6: 10 Best Big Pharma Stocks to Buy Now.NEWS7: COVID Update: Vaccine Booster Shots, Alternate Treatments Wrap Up.
2021-10-11: NEWS1: International SOS SVP details where doctors have been needed most.NEWS2: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference.NEWS3: Coronavirus: Doctor quotes Yogi Berra to urge everyone to 'let the data sort itself out'.NEWS4: J&J (JNJ) Seeks Stelara Label Expansion in Juvenile Arthritis.NEWS5: What Lies Ahead for Dow ETFs in Q3 Earnings?.NEWS6: Merck seeks emergency authorization for COVID pill.
2021-10-12: NEWS1: Breaking down the legality of workplace vaccine mandates.NEWS2: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS3: eMed CEO discusses what's next for COVID-19 testing.NEWS4: Dow Jones Leads Major Indexes Lower, But These Growth Stocks Soar.NEWS5: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations.NEWS6: Dow Jones Slips Ahead Of Bank Earnings; IBD 50 Jumps As Growth Stocks Rally.NEWS7: Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth.NEWS8: Pushing back on businesses’ ability to have a vaccine mandate is a bad idea: Doctor.NEWS9: J&J's Stoffels, who managed development of the company's COVID-19 shot, is retiring.NEWS10: UPDATE 3-U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boosters.NEWS11: 12 Best Long-Term Dividend Stocks To Buy Now.NEWS12: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire,  Effective December 31, 2021.NEWS13: 3 Dividend Stocks That Should Pay You for the Rest of Your Life.NEWS14: Johnson & Johnson's Top Scientist, Stoffels, to Retire at Year-End.NEWS15: FDA Advisory Panel Will Debate J&J and Moderna Boosters This Week.
2021-10-13: NEWS1: UPDATE 2-J&J COVID-19 shot gets better boost from Moderna or Pfizer in NIH study.NEWS2: Johnson & Johnson Covid-19 Booster Shot Bolsters Immune Defense, FDA Staff Say.NEWS3: Is JNJ Stock A Buy After Asking FDA To Authorize Its Covid Booster Shot?.NEWS4: Will J&J's Covid Booster Get FDA's Blessing? Here's Why It Looks Likely.NEWS5: Johnson & Johnson Booster Shot May Bolster Immune Response, FDA Staff Says.NEWS6: U.S. to open Canada, Mexico borders for vaccinated visitors.NEWS7: How Johnson & Johnson Has Pioneered in the Battle Against HIV/AIDS.NEWS8: Americans are losing trust in Biden’s handling of the COVID pandemic: poll.NEWS9: FDA Staff Shows Cautious Optimism for J&J's Booster Shot.NEWS10: Relying on J&J's analyses to assess vaccine booster dose data -U.S. FDA staff.NEWS11: These quality dividend stocks have a built-in advantage that can keep you ahead of inflation in 2022.NEWS12: 3 Top Healthcare Stocks to Buy Right Now.NEWS13: J&J Gains as FDA Says Its Covid Booster Shot Helps Immunity.NEWS14: Got $1,000? 2 Super-Smart Stocks That Could Make You Richer Over the Next Decade.NEWS15: Johnson & Johnson to Host Business Review Highlighting Pharmaceuticals.NEWS16: An FDA Advisory Panel Will Debate Moderna and J&J Boosters This Week.

Answer: Rise